

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular glucuronidation (GO:0052695) | 9.77899093 |
| 2 | glucuronate metabolic process (GO:0019585) | 9.24835355 |
| 3 | uronic acid metabolic process (GO:0006063) | 9.24835355 |
| 4 | flavonoid metabolic process (GO:0009812) | 8.65413060 |
| 5 | * glycoside metabolic process (GO:0016137) | 8.49667865 |
| 6 | progesterone metabolic process (GO:0042448) | 8.15138828 |
| 7 | * primary alcohol catabolic process (GO:0034310) | 7.25841005 |
| 8 | retinal metabolic process (GO:0042574) | 6.34128542 |
| 9 | C21-steroid hormone metabolic process (GO:0008207) | 6.26001486 |
| 10 | glucose 6-phosphate metabolic process (GO:0051156) | 6.08398577 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 5.97423758 |
| 12 | pentose-phosphate shunt (GO:0006098) | 5.83212125 |
| 13 | NADPH regeneration (GO:0006740) | 5.72660784 |
| 14 | cytidine deamination (GO:0009972) | 5.72292574 |
| 15 | cytidine metabolic process (GO:0046087) | 5.72292574 |
| 16 | cytidine catabolic process (GO:0006216) | 5.72292574 |
| 17 | maintenance of protein location in nucleus (GO:0051457) | 5.25464793 |
| 18 | cysteine metabolic process (GO:0006534) | 5.18726307 |
| 19 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.05370998 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03350485 |
| 21 | phenylpropanoid metabolic process (GO:0009698) | 4.94434874 |
| 22 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.89947067 |
| 23 | glucose catabolic process (GO:0006007) | 4.79913053 |
| 24 | ethanol oxidation (GO:0006069) | 4.78414017 |
| 25 | interferon-gamma production (GO:0032609) | 4.78385605 |
| 26 | bile acid and bile salt transport (GO:0015721) | 4.72221001 |
| 27 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.69215933 |
| 28 | intestinal absorption (GO:0050892) | 4.68918166 |
| 29 | pentose metabolic process (GO:0019321) | 4.66543849 |
| 30 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.64475457 |
| 31 | drug transmembrane transport (GO:0006855) | 4.56310530 |
| 32 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.56101031 |
| 33 | regulation of response to osmotic stress (GO:0047484) | 4.51009370 |
| 34 | muscle organ morphogenesis (GO:0048644) | 4.38163827 |
| 35 | prostanoid metabolic process (GO:0006692) | 4.36087302 |
| 36 | prostaglandin metabolic process (GO:0006693) | 4.36087302 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.34086725 |
| 38 | L-phenylalanine metabolic process (GO:0006558) | 4.34086725 |
| 39 | * cellular aldehyde metabolic process (GO:0006081) | 4.31360791 |
| 40 | ethanol metabolic process (GO:0006067) | 4.28578044 |
| 41 | retinoic acid metabolic process (GO:0042573) | 4.19754817 |
| 42 | protein localization to kinetochore (GO:0034501) | 4.18764025 |
| 43 | negative regulation of epidermis development (GO:0045683) | 4.16402987 |
| 44 | drug metabolic process (GO:0017144) | 4.11530068 |
| 45 | negative regulation of telomerase activity (GO:0051974) | 4.06266959 |
| 46 | * secondary metabolic process (GO:0019748) | 4.04728526 |
| 47 | negative regulation of hormone metabolic process (GO:0032351) | 4.04038897 |
| 48 | rRNA methylation (GO:0031167) | 4.02778391 |
| 49 | somite rostral/caudal axis specification (GO:0032525) | 4.02127585 |
| 50 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.97967495 |
| 51 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.87904392 |
| 52 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.87138566 |
| 53 | rRNA transcription (GO:0009303) | 3.84521721 |
| 54 | regulation of vitamin metabolic process (GO:0030656) | 3.81709007 |
| 55 | positive regulation of protein deacetylation (GO:0090312) | 3.77462991 |
| 56 | phagocytosis, recognition (GO:0006910) | 3.77402130 |
| 57 | fat-soluble vitamin catabolic process (GO:0042363) | 3.76361267 |
| 58 | vitamin catabolic process (GO:0009111) | 3.76361267 |
| 59 | histone H4-K8 acetylation (GO:0043982) | 3.70888120 |
| 60 | histone H4-K5 acetylation (GO:0043981) | 3.70888120 |
| 61 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.69646955 |
| 62 | bile acid metabolic process (GO:0008206) | 3.68259310 |
| 63 | rRNA modification (GO:0000154) | 3.67087474 |
| 64 | NADP metabolic process (GO:0006739) | 3.62273325 |
| 65 | complement activation, alternative pathway (GO:0006957) | 3.59487126 |
| 66 | drug transport (GO:0015893) | 3.56663222 |
| 67 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.54997531 |
| 68 | renal absorption (GO:0070293) | 3.54780366 |
| 69 | * primary alcohol metabolic process (GO:0034308) | 3.53751235 |
| 70 | regulation of cilium movement (GO:0003352) | 3.49555107 |
| 71 | response to prostaglandin (GO:0034694) | 3.49352098 |
| 72 | cofactor catabolic process (GO:0051187) | 3.48310433 |
| 73 | L-phenylalanine catabolic process (GO:0006559) | 3.44429407 |
| 74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.44429407 |
| 75 | nucleoside transmembrane transport (GO:1901642) | 3.43978209 |
| 76 | negative regulation of phagocytosis (GO:0050765) | 3.43890166 |
| 77 | * retinoid metabolic process (GO:0001523) | 3.42945522 |
| 78 | * digestion (GO:0007586) | 3.40917385 |
| 79 | response to nitrosative stress (GO:0051409) | 3.39373862 |
| 80 | DNA replication checkpoint (GO:0000076) | 3.38472641 |
| 81 | * diterpenoid metabolic process (GO:0016101) | 3.38267761 |
| 82 | epoxygenase P450 pathway (GO:0019373) | 3.35668094 |
| 83 | regulation of translation in response to stress (GO:0043555) | 3.32644566 |
| 84 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.32326327 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 3.30958580 |
| 86 | * cellular ketone metabolic process (GO:0042180) | 3.30541756 |
| 87 | GDP-mannose metabolic process (GO:0019673) | 3.28385896 |
| 88 | cellular response to cadmium ion (GO:0071276) | 3.27811225 |
| 89 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.26972857 |
| 90 | positive regulation of defense response to virus by host (GO:0002230) | 3.26690517 |
| 91 | positive regulation of histone deacetylation (GO:0031065) | 3.23698917 |
| 92 | glutathione biosynthetic process (GO:0006750) | 3.22415578 |
| 93 | regulation of bile acid biosynthetic process (GO:0070857) | 3.20906351 |
| 94 | primitive streak formation (GO:0090009) | 3.20636916 |
| 95 | cellular hormone metabolic process (GO:0034754) | 3.18805091 |
| 96 | urea metabolic process (GO:0019627) | 3.18009284 |
| 97 | regulation of protein activation cascade (GO:2000257) | 3.17544170 |
| 98 | pseudouridine synthesis (GO:0001522) | 3.17151582 |
| 99 | cellular response to prostaglandin stimulus (GO:0071379) | 3.16593229 |
| 100 | * terpenoid metabolic process (GO:0006721) | 3.15435729 |
| 101 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.14079152 |
| 102 | histone H4-K12 acetylation (GO:0043983) | 3.13472572 |
| 103 | mitotic sister chromatid segregation (GO:0000070) | 3.11286549 |
| 104 | negative regulation of telomere maintenance (GO:0032205) | 3.11200071 |
| 105 | xenobiotic metabolic process (GO:0006805) | 3.08872593 |
| 106 | regulation of necroptotic process (GO:0060544) | 3.08048746 |
| 107 | cullin deneddylation (GO:0010388) | 3.07795771 |
| 108 | ribosomal small subunit biogenesis (GO:0042274) | 3.07619218 |
| 109 | androgen biosynthetic process (GO:0006702) | 3.07129507 |
| 110 | maintenance of protein localization in organelle (GO:0072595) | 3.04946396 |
| 111 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.02599286 |
| 112 | urea cycle (GO:0000050) | 2.97870792 |
| 113 | hormone catabolic process (GO:0042447) | 2.97289014 |
| 114 | negative regulation of necroptotic process (GO:0060546) | 2.96998177 |
| 115 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.96734133 |
| 116 | protein localization to chromosome, centromeric region (GO:0071459) | 2.96097749 |
| 117 | regulation of complement activation (GO:0030449) | 2.95345027 |
| 118 | ribosomal small subunit assembly (GO:0000028) | 2.95266522 |
| 119 | nucleoside transport (GO:0015858) | 2.94875447 |
| 120 | phagocytosis, engulfment (GO:0006911) | 2.93551869 |
| 121 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.91437236 |
| 122 | phenol-containing compound catabolic process (GO:0019336) | 2.91212877 |
| 123 | response to interferon-beta (GO:0035456) | 2.88176405 |
| 124 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.87952833 |
| 125 | valine metabolic process (GO:0006573) | 2.87895701 |
| 126 | xenobiotic catabolic process (GO:0042178) | 2.87334897 |
| 127 | protein deneddylation (GO:0000338) | 2.86704541 |
| 128 | regulation of triglyceride catabolic process (GO:0010896) | 2.86341671 |
| 129 | cyclooxygenase pathway (GO:0019371) | 2.83496629 |
| 130 | coenzyme catabolic process (GO:0009109) | 2.83041630 |
| 131 | vitamin transmembrane transport (GO:0035461) | 2.82801260 |
| 132 | histone H4-K16 acetylation (GO:0043984) | 2.82646065 |
| 133 | B cell mediated immunity (GO:0019724) | 2.81952103 |
| 134 | arachidonic acid metabolic process (GO:0019369) | 2.81411794 |
| 135 | nitrogen cycle metabolic process (GO:0071941) | 2.80339895 |
| 136 | glutathione metabolic process (GO:0006749) | 2.80028618 |
| 137 | formation of translation preinitiation complex (GO:0001731) | 2.79145980 |
| 138 | * quinone metabolic process (GO:1901661) | 2.76821119 |
| 139 | mitochondrion distribution (GO:0048311) | 2.76794651 |
| 140 | DNA damage response, detection of DNA damage (GO:0042769) | 2.76603352 |
| 141 | macroautophagy (GO:0016236) | 2.76479220 |
| 142 | negative regulation of bone resorption (GO:0045779) | 2.76062131 |
| 143 | glutamate metabolic process (GO:0006536) | 2.75985854 |
| 144 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.72572852 |
| 145 | negative regulation of interleukin-2 production (GO:0032703) | 2.71811421 |
| 146 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.71482036 |
| 147 | * isoprenoid metabolic process (GO:0006720) | 2.70410326 |
| 148 | megakaryocyte development (GO:0035855) | 2.69565043 |
| 149 | mitochondrial DNA replication (GO:0006264) | 2.69400280 |
| 150 | notochord development (GO:0030903) | 2.69066395 |
| 151 | glutathione derivative biosynthetic process (GO:1901687) | 2.66511673 |
| 152 | glutathione derivative metabolic process (GO:1901685) | 2.66511673 |
| 153 | response to dietary excess (GO:0002021) | 2.62552575 |
| 154 | fatty acid derivative transport (GO:1901571) | 2.62150623 |
| 155 | icosanoid transport (GO:0071715) | 2.62150623 |
| 156 | natural killer cell differentiation (GO:0001779) | 2.60470992 |
| 157 | response to peptidoglycan (GO:0032494) | 2.59701451 |
| 158 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.59165242 |
| 159 | cardiovascular system development (GO:0072358) | 2.59079573 |
| 160 | heme transport (GO:0015886) | 2.59032927 |
| 161 | ribosome biogenesis (GO:0042254) | 2.58504911 |
| 162 | establishment of endothelial barrier (GO:0061028) | 2.57197328 |
| 163 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.56972995 |
| 164 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.56972995 |
| 165 | hexose catabolic process (GO:0019320) | 2.56043133 |
| 166 | L-ascorbic acid metabolic process (GO:0019852) | 2.55907028 |
| 167 | chromatin assembly (GO:0031497) | 2.55210377 |
| 168 | regulation of telomerase activity (GO:0051972) | 2.54648544 |
| 169 | pinocytosis (GO:0006907) | 2.54459078 |
| 170 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.54286314 |
| 171 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.53446434 |
| 172 | melanosome organization (GO:0032438) | 2.52584254 |
| 173 | negative regulation of gene silencing (GO:0060969) | 2.52126076 |
| 174 | biotin metabolic process (GO:0006768) | 2.52007095 |
| 175 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.51674308 |
| 176 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.51674308 |
| 177 | positive regulation of lipid catabolic process (GO:0050996) | 2.49163410 |
| 178 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.48863176 |
| 179 | pigment granule organization (GO:0048753) | 2.47745157 |
| 180 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.47545184 |
| 181 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.46592092 |
| 182 | desmosome organization (GO:0002934) | 2.46576104 |
| 183 | icosanoid metabolic process (GO:0006690) | 2.46058467 |
| 184 | fatty acid derivative metabolic process (GO:1901568) | 2.46058467 |
| 185 | natural killer cell activation (GO:0030101) | 2.45323355 |
| 186 | glyoxylate metabolic process (GO:0046487) | 2.44820228 |
| 187 | response to interferon-alpha (GO:0035455) | 2.44634018 |
| 188 | regulation of cholesterol homeostasis (GO:2000188) | 2.44233809 |
| 189 | arachidonic acid secretion (GO:0050482) | 2.44232753 |
| 190 | icosanoid secretion (GO:0032309) | 2.44232753 |
| 191 | transcription from mitochondrial promoter (GO:0006390) | 2.43954002 |
| 192 | heparin metabolic process (GO:0030202) | 2.43576641 |
| 193 | cellular anion homeostasis (GO:0030002) | 2.40552596 |
| 194 | * daunorubicin metabolic process (GO:0044597) | 17.4303482 |
| 195 | * polyketide metabolic process (GO:0030638) | 17.4303482 |
| 196 | * doxorubicin metabolic process (GO:0044598) | 17.4303482 |
| 197 | * aminoglycoside antibiotic metabolic process (GO:0030647) | 15.2073512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.14303971 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.65069579 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.11898827 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.79822661 |
| 5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 4.33625252 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.12682740 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.93569577 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.69258977 |
| 9 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.69258977 |
| 10 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.69258977 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63885169 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.30735582 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.29777175 |
| 14 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.29322505 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.20393608 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.05567458 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.99623536 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.84723099 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.65033897 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.64301835 |
| 21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.62762937 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.60929685 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.57925800 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.50874663 |
| 25 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.48366403 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37195746 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.34013877 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.32251924 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.29826223 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.26377517 |
| 31 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.20103004 |
| 32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.17298938 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17279684 |
| 34 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.16442384 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12562474 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.12018990 |
| 37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.09461869 |
| 38 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.06931500 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06319757 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05505521 |
| 41 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.97181855 |
| 42 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.92659927 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.92659927 |
| 44 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90970804 |
| 45 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.88163054 |
| 46 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.81227781 |
| 47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.80057170 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.78361521 |
| 49 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.76991228 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76404904 |
| 51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71645313 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68897484 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68891603 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.66998998 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65578953 |
| 56 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65216512 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.64879124 |
| 58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.63831227 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63824625 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63440704 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63252609 |
| 62 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62661940 |
| 63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62492053 |
| 64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.61031665 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.60811824 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59880255 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.58330428 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.57015741 |
| 69 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.55527060 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55239330 |
| 71 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55176755 |
| 72 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55040143 |
| 73 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.54933223 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.54411027 |
| 75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.53455434 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52957640 |
| 77 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.46159824 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45463930 |
| 79 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45347749 |
| 80 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44390258 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43325449 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42928410 |
| 83 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42697541 |
| 84 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.42425358 |
| 85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41996703 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41439041 |
| 87 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40996835 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40238008 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40238008 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.38636172 |
| 91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.38544985 |
| 92 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36883666 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36612878 |
| 94 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.36311589 |
| 95 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33931323 |
| 96 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.33931274 |
| 97 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33887701 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32823969 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30450307 |
| 100 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.30413117 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30387931 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30269613 |
| 103 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30066719 |
| 104 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.29443924 |
| 105 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.28839489 |
| 106 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.27772761 |
| 107 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27765969 |
| 108 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27158103 |
| 109 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22294209 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22109977 |
| 111 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22046319 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21910223 |
| 113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21741820 |
| 114 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.20955618 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17095917 |
| 116 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16685831 |
| 117 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16658475 |
| 118 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16230222 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.15901504 |
| 120 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15412264 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14763262 |
| 122 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14366429 |
| 123 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14263218 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12711038 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12581605 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11194919 |
| 127 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.11013863 |
| 128 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10650332 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09899183 |
| 130 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.08498827 |
| 131 | MYB_26560356_Chip-Seq_TH2_Human | 1.08283369 |
| 132 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07341356 |
| 133 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06574935 |
| 134 | * MYB_26560356_Chip-Seq_TH1_Human | 1.05479910 |
| 135 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.05030927 |
| 136 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04990393 |
| 137 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04280605 |
| 138 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04043758 |
| 139 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03834353 |
| 140 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.03607980 |
| 141 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03351529 |
| 142 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03085484 |
| 143 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.02044200 |
| 144 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01763564 |
| 145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01645607 |
| 146 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00966416 |
| 147 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00509071 |
| 148 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00373686 |
| 149 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99959789 |
| 150 | MAF_26560356_Chip-Seq_TH1_Human | 0.99958540 |
| 151 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99944020 |
| 152 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98879114 |
| 153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97472039 |
| 154 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97091185 |
| 155 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96426378 |
| 156 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.95595077 |
| 157 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94503851 |
| 158 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94104890 |
| 159 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93494448 |
| 160 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.92696189 |
| 161 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.92646596 |
| 162 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92275462 |
| 163 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92116669 |
| 164 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91144819 |
| 165 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90917552 |
| 166 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90522721 |
| 167 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90432126 |
| 168 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87990456 |
| 169 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87963756 |
| 170 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.87681835 |
| 171 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85851643 |
| 172 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84559616 |
| 173 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84546977 |
| 174 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83936786 |
| 175 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83609806 |
| 176 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82994643 |
| 177 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82626130 |
| 178 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82338791 |
| 179 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81309002 |
| 180 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81112593 |
| 181 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79987311 |
| 182 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76195170 |
| 183 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.76058953 |
| 184 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75982877 |
| 185 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.75490743 |
| 186 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74774584 |
| 187 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73273425 |
| 188 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72549279 |
| 189 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.71061250 |
| 190 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.70985777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.04927116 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.39049925 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 5.30347227 |
| 4 | MP0005365_abnormal_bile_salt | 5.08416773 |
| 5 | MP0005360_urolithiasis | 4.91017661 |
| 6 | MP0003252_abnormal_bile_duct | 4.13425252 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.72692455 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.59212749 |
| 9 | MP0002254_reproductive_system_inflammat | 3.58333180 |
| 10 | MP0003011_delayed_dark_adaptation | 3.51810236 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.88798827 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.86304517 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.83169742 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.74141343 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.73718699 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.58362557 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.57524669 |
| 18 | MP0003868_abnormal_feces_composition | 2.54805499 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.50094342 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.44528670 |
| 21 | MP0005332_abnormal_amino_acid | 2.19130071 |
| 22 | MP0000749_muscle_degeneration | 2.18614984 |
| 23 | MP0004858_abnormal_nervous_system | 2.09044987 |
| 24 | MP0006082_CNS_inflammation | 2.05784531 |
| 25 | MP0000343_altered_response_to | 2.03362419 |
| 26 | MP0008057_abnormal_DNA_replication | 2.03150941 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.01422043 |
| 28 | MP0005248_abnormal_Harderian_gland | 1.95328731 |
| 29 | MP0001853_heart_inflammation | 1.95238921 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.89668889 |
| 31 | MP0004957_abnormal_blastocyst_morpholog | 1.80613659 |
| 32 | MP0009840_abnormal_foam_cell | 1.77770123 |
| 33 | MP0000750_abnormal_muscle_regeneration | 1.71022078 |
| 34 | MP0003828_pulmonary_edema | 1.70934453 |
| 35 | MP0000490_abnormal_crypts_of | 1.70453544 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.70378095 |
| 37 | MP0009785_altered_susceptibility_to | 1.66690834 |
| 38 | MP0008007_abnormal_cellular_replicative | 1.64752570 |
| 39 | MP0005451_abnormal_body_composition | 1.63292369 |
| 40 | MP0005394_taste/olfaction_phenotype | 1.62537001 |
| 41 | MP0005499_abnormal_olfactory_system | 1.62537001 |
| 42 | MP0003186_abnormal_redox_activity | 1.62466450 |
| 43 | MP0003436_decreased_susceptibility_to | 1.59606106 |
| 44 | MP0005671_abnormal_response_to | 1.59154927 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.58693093 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.56668625 |
| 47 | MP0000609_abnormal_liver_physiology | 1.54338816 |
| 48 | MP0002127_abnormal_cardiovascular_syste | 1.54152161 |
| 49 | MP0000685_abnormal_immune_system | 1.46958458 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.45972574 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.44830288 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.43231808 |
| 53 | MP0002132_abnormal_respiratory_system | 1.40502439 |
| 54 | MP0001800_abnormal_humoral_immune | 1.38744103 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.38132428 |
| 56 | MP0005257_abnormal_intraocular_pressure | 1.37258632 |
| 57 | MP0005025_abnormal_response_to | 1.36464562 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.33303619 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.32983182 |
| 60 | MP0001790_abnormal_immune_system | 1.31826860 |
| 61 | MP0005387_immune_system_phenotype | 1.31826860 |
| 62 | MP0002796_impaired_skin_barrier | 1.29949166 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.29928206 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.29864167 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.29040554 |
| 66 | MP0001819_abnormal_immune_cell | 1.28362083 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 1.28001425 |
| 68 | MP0005266_abnormal_metabolism | 1.25957300 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 1.25578278 |
| 70 | MP0001873_stomach_inflammation | 1.25355365 |
| 71 | MP0002398_abnormal_bone_marrow | 1.24985570 |
| 72 | MP0002722_abnormal_immune_system | 1.24146104 |
| 73 | MP0009379_abnormal_foot_pigmentation | 1.22698858 |
| 74 | MP0000678_abnormal_parathyroid_gland | 1.21666603 |
| 75 | MP0004147_increased_porphyrin_level | 1.20888571 |
| 76 | MP0002405_respiratory_system_inflammati | 1.20300623 |
| 77 | MP0003077_abnormal_cell_cycle | 1.19773888 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.18512260 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.16662059 |
| 80 | MP0003195_calcinosis | 1.15510141 |
| 81 | MP0002723_abnormal_immune_serum | 1.15347282 |
| 82 | MP0000858_altered_metastatic_potential | 1.14412472 |
| 83 | MP0000716_abnormal_immune_system | 1.13777506 |
| 84 | MP0008961_abnormal_basal_metabolism | 1.11583333 |
| 85 | MP0005409_darkened_coat_color | 1.10598029 |
| 86 | MP0002429_abnormal_blood_cell | 1.10547087 |
| 87 | MP0001661_extended_life_span | 1.08847887 |
| 88 | MP0002419_abnormal_innate_immunity | 1.06710254 |
| 89 | MP0010630_abnormal_cardiac_muscle | 1.06185546 |
| 90 | MP0000372_irregular_coat_pigmentation | 1.05004746 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 1.04439694 |
| 92 | MP0003137_abnormal_impulse_conducting | 1.04423127 |
| 93 | MP0003279_aneurysm | 1.04421031 |
| 94 | MP0002269_muscular_atrophy | 1.04278718 |
| 95 | MP0003646_muscle_fatigue | 1.03988973 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 1.03943465 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03337568 |
| 98 | MP0008260_abnormal_autophagy | 1.02743293 |
| 99 | MP0001764_abnormal_homeostasis | 1.02614794 |
| 100 | MP0003122_maternal_imprinting | 1.02161561 |
| 101 | MP0004036_abnormal_muscle_relaxation | 1.01968250 |
| 102 | MP0003984_embryonic_growth_retardation | 0.99666117 |
| 103 | MP0000313_abnormal_cell_death | 0.99662051 |
| 104 | MP0002088_abnormal_embryonic_growth/wei | 0.99407624 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.98662836 |
| 106 | MP0005501_abnormal_skin_physiology | 0.98172107 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.97839789 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.97621505 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.97363443 |
| 110 | MP0001664_abnormal_digestion | 0.97337431 |
| 111 | MP0002970_abnormal_white_adipose | 0.97265444 |
| 112 | MP0005380_embryogenesis_phenotype | 0.95160397 |
| 113 | MP0001672_abnormal_embryogenesis/_devel | 0.95160397 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.94859472 |
| 115 | MP0004087_abnormal_muscle_fiber | 0.93567512 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.92909674 |
| 117 | MP0005330_cardiomyopathy | 0.90956791 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.90589901 |
| 119 | MP0004185_abnormal_adipocyte_glucose | 0.89923428 |
| 120 | MP0010155_abnormal_intestine_physiology | 0.89707158 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.89274705 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.88472488 |
| 123 | MP0010094_abnormal_chromosome_stability | 0.87212060 |
| 124 | MP0005408_hypopigmentation | 0.86732533 |
| 125 | MP0000350_abnormal_cell_proliferation | 0.86356100 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.85016435 |
| 127 | MP0002106_abnormal_muscle_physiology | 0.84740960 |
| 128 | MP0000462_abnormal_digestive_system | 0.84665063 |
| 129 | MP0001545_abnormal_hematopoietic_system | 0.83647864 |
| 130 | MP0005397_hematopoietic_system_phenotyp | 0.83647864 |
| 131 | MP0000703_abnormal_thymus_morphology | 0.83335284 |
| 132 | MP0005310_abnormal_salivary_gland | 0.83239957 |
| 133 | MP0002972_abnormal_cardiac_muscle | 0.83126688 |
| 134 | MP0009333_abnormal_splenocyte_physiolog | 0.82935335 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.82832818 |
| 136 | MP0000598_abnormal_liver_morphology | 0.82463491 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.81899459 |
| 138 | MP0001849_ear_inflammation | 0.81546686 |
| 139 | MP0008469_abnormal_protein_level | 0.80933726 |
| 140 | MP0005165_increased_susceptibility_to | 0.80863366 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.80494067 |
| 142 | MP0004043_abnormal_pH_regulation | 0.80217833 |
| 143 | MP0000049_abnormal_middle_ear | 0.79983443 |
| 144 | MP0005164_abnormal_response_to | 0.79001647 |
| 145 | MP0005670_abnormal_white_adipose | 0.78143366 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.77729050 |
| 147 | MP0005376_homeostasis/metabolism_phenot | 0.76877211 |
| 148 | MP0000477_abnormal_intestine_morphology | 0.76689212 |
| 149 | MP0002006_tumorigenesis | 0.75285846 |
| 150 | MP0005023_abnormal_wound_healing | 0.75032541 |
| 151 | MP0002876_abnormal_thyroid_physiology | 0.74999945 |
| 152 | MP0009115_abnormal_fat_cell | 0.74857845 |
| 153 | MP0003950_abnormal_plasma_membrane | 0.74355098 |
| 154 | MP0003656_abnormal_erythrocyte_physiolo | 0.73270306 |
| 155 | MP0009697_abnormal_copulation | 0.72877507 |
| 156 | MP0000383_abnormal_hair_follicle | 0.71828274 |
| 157 | MP0001730_embryonic_growth_arrest | 0.71162203 |
| 158 | MP0009642_abnormal_blood_homeostasis | 0.68763917 |
| 159 | MP0001216_abnormal_epidermal_layer | 0.66495170 |
| 160 | MP0001765_abnormal_ion_homeostasis | 0.66451856 |
| 161 | MP0004272_abnormal_basement_membrane | 0.61504004 |
| 162 | MP0000762_abnormal_tongue_morphology | 0.60789012 |
| 163 | MP0009765_abnormal_xenobiotic_induced | 0.60670428 |
| 164 | MP0001756_abnormal_urination | 0.57349584 |
| 165 | MP0003091_abnormal_cell_migration | 0.56797965 |
| 166 | MP0000627_abnormal_mammary_gland | 0.56794057 |
| 167 | MP0003943_abnormal_hepatobiliary_system | 0.55082259 |
| 168 | MP0002089_abnormal_postnatal_growth/wei | 0.54118751 |
| 169 | MP0003866_abnormal_defecation | 0.52907363 |
| 170 | MP0005166_decreased_susceptibility_to | 0.49009198 |
| 171 | MP0002098_abnormal_vibrissa_morphology | 0.48370194 |
| 172 | MP0008872_abnormal_physiological_respon | 0.46900263 |
| 173 | MP0006138_congestive_heart_failure | 0.45760248 |
| 174 | MP0001919_abnormal_reproductive_system | 0.45561907 |
| 175 | MP0000538_abnormal_urinary_bladder | 0.44346049 |
| 176 | MP0009764_decreased_sensitivity_to | 0.44131449 |
| 177 | MP0009053_abnormal_anal_canal | 0.43969614 |
| 178 | MP0000013_abnormal_adipose_tissue | 0.42636329 |
| 179 | MP0009763_increased_sensitivity_to | 0.42368153 |
| 180 | MP0005193_abnormal_anterior_eye | 0.41709484 |
| 181 | MP0008873_increased_physiological_sensi | 0.41326721 |
| 182 | MP0000566_synostosis | 0.40958834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Conjugated hyperbilirubinemia (HP:0002908) | 8.62652062 |
| 2 | Sex reversal (HP:0012245) | 7.39562318 |
| 3 | Abnormal sex determination (HP:0012244) | 7.39562318 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44627538 |
| 5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.09402758 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 5.40176786 |
| 7 | Hydroxyprolinuria (HP:0003080) | 5.40176786 |
| 8 | Bilateral microphthalmos (HP:0007633) | 5.31668507 |
| 9 | Fat malabsorption (HP:0002630) | 5.09747278 |
| 10 | Multiple enchondromatosis (HP:0005701) | 5.02970729 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.86560453 |
| 12 | Steatorrhea (HP:0002570) | 4.66529064 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.64575900 |
| 14 | Complement deficiency (HP:0004431) | 4.47005730 |
| 15 | Abnormality of complement system (HP:0005339) | 4.16632047 |
| 16 | Reduced antithrombin III activity (HP:0001976) | 3.96043438 |
| 17 | Tetraparesis (HP:0002273) | 3.89969493 |
| 18 | Prolonged neonatal jaundice (HP:0006579) | 3.85980225 |
| 19 | Hyperbilirubinemia (HP:0002904) | 3.85763406 |
| 20 | Glomerulonephritis (HP:0000099) | 3.68471048 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.67043279 |
| 22 | Ragged-red muscle fibers (HP:0003200) | 3.66348376 |
| 23 | Vascular calcification (HP:0004934) | 3.58546519 |
| 24 | Hypochromic microcytic anemia (HP:0004840) | 3.41725512 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 3.41206062 |
| 26 | Exercise-induced muscle cramps (HP:0003710) | 3.39962323 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39015049 |
| 28 | Aplastic anemia (HP:0001915) | 3.27004369 |
| 29 | Rib fusion (HP:0000902) | 3.25796922 |
| 30 | Vertebral compression fractures (HP:0002953) | 3.18781042 |
| 31 | Rectal fistula (HP:0100590) | 3.16844557 |
| 32 | Rectovaginal fistula (HP:0000143) | 3.16844557 |
| 33 | Hepatoblastoma (HP:0002884) | 3.13316706 |
| 34 | Focal segmental glomerulosclerosis (HP:0000097) | 3.10919607 |
| 35 | Cerebral palsy (HP:0100021) | 3.08262013 |
| 36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.06011398 |
| 37 | Testicular atrophy (HP:0000029) | 3.05361060 |
| 38 | Cardiovascular calcification (HP:0011915) | 3.05229695 |
| 39 | Intrahepatic cholestasis (HP:0001406) | 3.03958595 |
| 40 | Myositis (HP:0100614) | 2.98245065 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96459824 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96459824 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96459824 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.94802067 |
| 45 | Vaginal fistula (HP:0004320) | 2.94585635 |
| 46 | Hypolipoproteinemia (HP:0010981) | 2.94366050 |
| 47 | Abnormality of the Achilles tendon (HP:0005109) | 2.93806383 |
| 48 | Hypoplasia of the fovea (HP:0007750) | 2.93596558 |
| 49 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.93596558 |
| 50 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.89849925 |
| 51 | Ependymoma (HP:0002888) | 2.87601749 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.86160793 |
| 53 | Intestinal fistula (HP:0100819) | 2.85598822 |
| 54 | Nephritis (HP:0000123) | 2.80227931 |
| 55 | Nasal polyposis (HP:0100582) | 2.78597124 |
| 56 | Rhabdomyosarcoma (HP:0002859) | 2.75768319 |
| 57 | Abnormality of vitamin metabolism (HP:0100508) | 2.74774969 |
| 58 | Deep venous thrombosis (HP:0002625) | 2.73738759 |
| 59 | Xanthomatosis (HP:0000991) | 2.73120962 |
| 60 | Chromsome breakage (HP:0040012) | 2.72496840 |
| 61 | Prolonged partial thromboplastin time (HP:0003645) | 2.71842597 |
| 62 | Spontaneous abortion (HP:0005268) | 2.70953188 |
| 63 | Orchitis (HP:0100796) | 2.68817055 |
| 64 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.67970046 |
| 65 | Embryonal renal neoplasm (HP:0011794) | 2.67156066 |
| 66 | Abnormality of the nasal mucosa (HP:0000433) | 2.65155457 |
| 67 | Neoplasm of striated muscle (HP:0009728) | 2.64618933 |
| 68 | Glomerulosclerosis (HP:0000096) | 2.62774674 |
| 69 | Proximal tubulopathy (HP:0000114) | 2.62714232 |
| 70 | Partial duplication of thumb phalanx (HP:0009944) | 2.62625567 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.60015466 |
| 72 | Malnutrition (HP:0004395) | 2.58347018 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.55579906 |
| 74 | Rickets (HP:0002748) | 2.49816130 |
| 75 | Hyponatremia (HP:0002902) | 2.47307832 |
| 76 | Hemorrhage of the eye (HP:0011885) | 2.47082214 |
| 77 | Difficulty running (HP:0009046) | 2.45566791 |
| 78 | Glycosuria (HP:0003076) | 2.43988410 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 2.43988410 |
| 80 | Abnormality of the gastric mucosa (HP:0004295) | 2.43514072 |
| 81 | Hyperammonemia (HP:0001987) | 2.43173810 |
| 82 | Ventricular tachycardia (HP:0004756) | 2.40864808 |
| 83 | Broad face (HP:0000283) | 2.40213162 |
| 84 | Microvesicular hepatic steatosis (HP:0001414) | 2.39801118 |
| 85 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.37581781 |
| 86 | Abnormality of the fovea (HP:0000493) | 2.37124172 |
| 87 | Abnormal lung lobation (HP:0002101) | 2.36967745 |
| 88 | Trismus (HP:0000211) | 2.36001745 |
| 89 | Abnormality of the nasal septum (HP:0000419) | 2.34533094 |
| 90 | Paraparesis (HP:0002385) | 2.33880883 |
| 91 | Increased connective tissue (HP:0009025) | 2.33561213 |
| 92 | Progressive muscle weakness (HP:0003323) | 2.32125551 |
| 93 | Nausea (HP:0002018) | 2.31582654 |
| 94 | Hypercholesterolemia (HP:0003124) | 2.29284078 |
| 95 | Cheilitis (HP:0100825) | 2.25260271 |
| 96 | Oral leukoplakia (HP:0002745) | 2.21798018 |
| 97 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21626120 |
| 98 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21626120 |
| 99 | Abnormal protein glycosylation (HP:0012346) | 2.21626120 |
| 100 | Abnormal glycosylation (HP:0012345) | 2.21626120 |
| 101 | 3-Methylglutaconic aciduria (HP:0003535) | 2.21607342 |
| 102 | Recurrent abscess formation (HP:0002722) | 2.18814084 |
| 103 | Mitral stenosis (HP:0001718) | 2.18472672 |
| 104 | Bifid tongue (HP:0010297) | 2.18260565 |
| 105 | Reticulocytosis (HP:0001923) | 2.15848922 |
| 106 | Myoglobinuria (HP:0002913) | 2.15587700 |
| 107 | Short nail (HP:0001799) | 2.15315762 |
| 108 | Flat acetabular roof (HP:0003180) | 2.14806191 |
| 109 | Petechiae (HP:0000967) | 2.14773472 |
| 110 | Abnormality of the salivary glands (HP:0010286) | 2.14593630 |
| 111 | Partial duplication of the phalanx of hand (HP:0009999) | 2.13956076 |
| 112 | Micronodular cirrhosis (HP:0001413) | 2.12961536 |
| 113 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11688338 |
| 114 | Microretrognathia (HP:0000308) | 2.10474823 |
| 115 | Short middle phalanx of the 5th finger (HP:0004220) | 2.09124520 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 2.08436950 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08436950 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 2.06949092 |
| 119 | Horizontal nystagmus (HP:0000666) | 2.04389986 |
| 120 | Elevated alkaline phosphatase (HP:0003155) | 2.03963332 |
| 121 | Subacute progressive viral hepatitis (HP:0006572) | 2.03443484 |
| 122 | Gout (HP:0001997) | 2.01237730 |
| 123 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.00479819 |
| 124 | Renal tubular acidosis (HP:0001947) | 2.00110246 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 1.99638096 |
| 126 | Increased serum ferritin (HP:0003281) | 1.98762787 |
| 127 | Preauricular skin tag (HP:0000384) | 1.97564622 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.95143255 |
| 129 | Achilles tendon contracture (HP:0001771) | 1.94584080 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94253673 |
| 131 | Fused cervical vertebrae (HP:0002949) | 1.94005730 |
| 132 | Abdominal distention (HP:0003270) | 1.93324713 |
| 133 | Preauricular pit (HP:0004467) | 1.93004272 |
| 134 | Periauricular skin pits (HP:0100277) | 1.93004272 |
| 135 | Nasolacrimal duct obstruction (HP:0000579) | 1.91693941 |
| 136 | Combined immunodeficiency (HP:0005387) | 1.91025684 |
| 137 | Myelodysplasia (HP:0002863) | 1.90199253 |
| 138 | Hypochromic anemia (HP:0001931) | 1.88391241 |
| 139 | Meckel diverticulum (HP:0002245) | 1.86022224 |
| 140 | Back pain (HP:0003418) | 1.85670758 |
| 141 | Late onset (HP:0003584) | 1.84951605 |
| 142 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84198717 |
| 143 | Selective tooth agenesis (HP:0001592) | 1.84046123 |
| 144 | Amyloidosis (HP:0011034) | 1.83909641 |
| 145 | IgM deficiency (HP:0002850) | 1.83715505 |
| 146 | Abnormal urine phosphate concentration (HP:0012599) | 1.82931988 |
| 147 | Cone-rod dystrophy (HP:0000548) | 1.82331441 |
| 148 | Hyperphosphaturia (HP:0003109) | 1.82205942 |
| 149 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.81705687 |
| 150 | Subaortic stenosis (HP:0001682) | 1.81705687 |
| 151 | Hypokinesia (HP:0002375) | 1.81337415 |
| 152 | Short 5th finger (HP:0009237) | 1.81196458 |
| 153 | Tongue fasciculations (HP:0001308) | 1.80807186 |
| 154 | Thrombocytosis (HP:0001894) | 1.80402753 |
| 155 | Adrenal hypoplasia (HP:0000835) | 1.79413814 |
| 156 | Abnormality of sodium homeostasis (HP:0010931) | 1.79073372 |
| 157 | Abnormality of T cell physiology (HP:0011840) | 1.78830588 |
| 158 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.78362560 |
| 159 | Renal tubular dysfunction (HP:0000124) | 1.78297156 |
| 160 | Neonatal death (HP:0003811) | 1.76948972 |
| 161 | Rough bone trabeculation (HP:0100670) | 1.76667634 |
| 162 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75681669 |
| 163 | Abnormality of nucleobase metabolism (HP:0010932) | 1.75324853 |
| 164 | Coarse hair (HP:0002208) | 1.74798962 |
| 165 | Chest pain (HP:0100749) | 1.74154937 |
| 166 | Sparse eyelashes (HP:0000653) | 1.74063601 |
| 167 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.73386613 |
| 168 | Ileus (HP:0002595) | 1.72131027 |
| 169 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.71685644 |
| 170 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71372308 |
| 171 | Elfin facies (HP:0004428) | 1.71307685 |
| 172 | Skin tags (HP:0010609) | 1.71263950 |
| 173 | Cellulitis (HP:0100658) | 1.70424293 |
| 174 | Abnormal trabecular bone morphology (HP:0100671) | 1.70289775 |
| 175 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.69987801 |
| 176 | Muscle fibrillation (HP:0010546) | 1.69729095 |
| 177 | Poor head control (HP:0002421) | 1.69383617 |
| 178 | Abnormality of the ileum (HP:0001549) | 1.68133494 |
| 179 | Abnormality of the pleura (HP:0002103) | 1.68071790 |
| 180 | Abnormality of glycolysis (HP:0004366) | 1.67640042 |
| 181 | Increased serum pyruvate (HP:0003542) | 1.67640042 |
| 182 | Bone pain (HP:0002653) | 1.67548179 |
| 183 | Hyperuricemia (HP:0002149) | 1.66703624 |
| 184 | Increased purine levels (HP:0004368) | 1.66703624 |
| 185 | Right ventricular cardiomyopathy (HP:0011663) | 1.66475634 |
| 186 | Abnormality of the lower motor neuron (HP:0002366) | 1.66188073 |
| 187 | Short humerus (HP:0005792) | 1.66056853 |
| 188 | Medulloblastoma (HP:0002885) | 1.65948729 |
| 189 | Generalized amyotrophy (HP:0003700) | 1.65763158 |
| 190 | Recurrent viral infections (HP:0004429) | 1.64210896 |
| 191 | Megaloblastic anemia (HP:0001889) | 1.63984246 |
| 192 | Exocrine pancreatic insufficiency (HP:0001738) | 1.63615326 |
| 193 | Exercise-induced myalgia (HP:0003738) | 1.63239110 |
| 194 | Abnormal glucose tolerance (HP:0001952) | 1.63040314 |
| 195 | Abnormality of chromosome segregation (HP:0002916) | 1.62257920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 8.52932305 |
| 2 | CDK12 | 5.59896959 |
| 3 | ERN1 | 5.01960402 |
| 4 | MET | 4.20379698 |
| 5 | GRK5 | 3.61985749 |
| 6 | ERBB4 | 3.50338655 |
| 7 | TGFBR2 | 3.44651396 |
| 8 | GRK6 | 3.39623855 |
| 9 | CSF1R | 3.38303446 |
| 10 | ADRBK2 | 2.74383959 |
| 11 | MATK | 2.49933278 |
| 12 | GRK7 | 2.43115131 |
| 13 | KIT | 2.39502286 |
| 14 | GRK1 | 2.25364428 |
| 15 | STK10 | 2.07942916 |
| 16 | DDR2 | 2.04232987 |
| 17 | FLT3 | 2.02315947 |
| 18 | TESK1 | 2.00670798 |
| 19 | PRKG2 | 1.84828363 |
| 20 | MAPK7 | 1.68665835 |
| 21 | MAP2K3 | 1.65470330 |
| 22 | PBK | 1.63265597 |
| 23 | MOS | 1.59780385 |
| 24 | MUSK | 1.57873787 |
| 25 | EIF2AK1 | 1.56767317 |
| 26 | TTK | 1.50983156 |
| 27 | FGFR4 | 1.42006193 |
| 28 | SIK1 | 1.39701564 |
| 29 | MAP3K12 | 1.37406058 |
| 30 | BCKDK | 1.37086363 |
| 31 | CDK7 | 1.35841844 |
| 32 | PDGFRA | 1.33232418 |
| 33 | MYLK | 1.29888682 |
| 34 | PIK3CG | 1.29392410 |
| 35 | PAK4 | 1.27083049 |
| 36 | BMX | 1.24793592 |
| 37 | TLK1 | 1.23904604 |
| 38 | NME2 | 1.22283963 |
| 39 | MAPK11 | 1.20040021 |
| 40 | IRAK4 | 1.19960256 |
| 41 | ICK | 1.17983375 |
| 42 | TYK2 | 1.13547608 |
| 43 | MELK | 1.12545133 |
| 44 | MAP4K1 | 1.12413729 |
| 45 | MAP2K6 | 1.09894906 |
| 46 | CAMK4 | 1.09622329 |
| 47 | IRAK2 | 1.08971065 |
| 48 | TTN | 1.05657796 |
| 49 | BTK | 1.04235539 |
| 50 | PIM2 | 1.01673609 |
| 51 | LIMK1 | 1.01644279 |
| 52 | LMTK2 | 0.97480799 |
| 53 | TEC | 0.95869828 |
| 54 | CDC42BPA | 0.95604928 |
| 55 | CDK8 | 0.95040372 |
| 56 | IKBKB | 0.94477730 |
| 57 | MAPKAPK3 | 0.94211022 |
| 58 | BLK | 0.93307337 |
| 59 | TBK1 | 0.93181927 |
| 60 | CDK9 | 0.92210250 |
| 61 | JAK3 | 0.91546741 |
| 62 | MAP3K7 | 0.90934132 |
| 63 | MAP3K2 | 0.90560852 |
| 64 | BRSK1 | 0.88820501 |
| 65 | ZAP70 | 0.88628494 |
| 66 | OBSCN | 0.88085143 |
| 67 | HIPK2 | 0.86923375 |
| 68 | MAPK12 | 0.86533070 |
| 69 | PTK2 | 0.85475160 |
| 70 | IRAK1 | 0.84382428 |
| 71 | MAP3K10 | 0.82497220 |
| 72 | PRKCI | 0.81340708 |
| 73 | ADRBK1 | 0.81043461 |
| 74 | ARAF | 0.79900044 |
| 75 | IRAK3 | 0.79831325 |
| 76 | RPS6KB2 | 0.77673694 |
| 77 | EIF2AK2 | 0.77163963 |
| 78 | FGFR3 | 0.76952636 |
| 79 | MAP3K14 | 0.69665040 |
| 80 | WNK1 | 0.69009402 |
| 81 | CAMK2G | 0.68354730 |
| 82 | PDK2 | 0.67580796 |
| 83 | TRIB3 | 0.65515616 |
| 84 | TXK | 0.62430331 |
| 85 | SYK | 0.62331544 |
| 86 | PRPF4B | 0.60736160 |
| 87 | NTRK1 | 0.60294486 |
| 88 | ITK | 0.58029935 |
| 89 | TGFBR1 | 0.57705200 |
| 90 | EIF2AK3 | 0.56307501 |
| 91 | CHEK2 | 0.56018475 |
| 92 | IGF1R | 0.55126827 |
| 93 | AKT2 | 0.54464713 |
| 94 | SMG1 | 0.53892909 |
| 95 | BUB1 | 0.53319249 |
| 96 | CSK | 0.53208149 |
| 97 | MST4 | 0.52953492 |
| 98 | LYN | 0.52159130 |
| 99 | STK39 | 0.51449316 |
| 100 | PLK1 | 0.50866676 |
| 101 | MAP2K7 | 0.50601076 |
| 102 | VRK1 | 0.50276286 |
| 103 | LCK | 0.49905321 |
| 104 | WEE1 | 0.49854230 |
| 105 | MAP3K8 | 0.48698825 |
| 106 | HCK | 0.48541959 |
| 107 | SCYL2 | 0.48366295 |
| 108 | MAP3K9 | 0.48337185 |
| 109 | STK4 | 0.47531214 |
| 110 | CHUK | 0.47159889 |
| 111 | PHKG1 | 0.46123728 |
| 112 | TYRO3 | 0.45937834 |
| 113 | LRRK2 | 0.45373280 |
| 114 | TRPM7 | 0.45262873 |
| 115 | PTK6 | 0.44492950 |
| 116 | FGR | 0.44098381 |
| 117 | AURKA | 0.42815352 |
| 118 | NEK1 | 0.42709825 |
| 119 | PRKCD | 0.42709402 |
| 120 | ABL2 | 0.42668297 |
| 121 | PKN2 | 0.42285610 |
| 122 | EPHA2 | 0.42257096 |
| 123 | LATS2 | 0.42096023 |
| 124 | MAP2K2 | 0.41745051 |
| 125 | DAPK1 | 0.41625381 |
| 126 | CDK4 | 0.41484265 |
| 127 | CAMK2B | 0.40915950 |
| 128 | BRSK2 | 0.40822326 |
| 129 | PRKAA2 | 0.40418768 |
| 130 | PIK3CA | 0.40203386 |
| 131 | IKBKE | 0.39459503 |
| 132 | MARK2 | 0.38808283 |
| 133 | CAMK2D | 0.38633183 |
| 134 | PRKCE | 0.38505175 |
| 135 | TNK2 | 0.37300624 |
| 136 | MAP2K4 | 0.36776342 |
| 137 | PDK3 | 0.36335311 |
| 138 | PDK4 | 0.36335311 |
| 139 | RIPK1 | 0.36133645 |
| 140 | ZAK | 0.35222579 |
| 141 | PDPK1 | 0.35067786 |
| 142 | PIM1 | 0.34590854 |
| 143 | EPHB2 | 0.34483986 |
| 144 | TAOK2 | 0.34412485 |
| 145 | EPHA3 | 0.33849717 |
| 146 | ACVR1B | 0.32964469 |
| 147 | MAP3K1 | 0.32769539 |
| 148 | MAPKAPK2 | 0.31177890 |
| 149 | STK38 | 0.30710671 |
| 150 | MAPK4 | 0.30040483 |
| 151 | RIPK4 | 0.29923270 |
| 152 | CAMK1 | 0.29486428 |
| 153 | CASK | 0.29263529 |
| 154 | MAP3K3 | 0.28873673 |
| 155 | NME1 | 0.26558099 |
| 156 | AURKB | 0.26532272 |
| 157 | PHKG2 | 0.26207436 |
| 158 | SRC | 0.24718129 |
| 159 | BRAF | 0.24547009 |
| 160 | FER | 0.20770254 |
| 161 | ILK | 0.20661524 |
| 162 | NEK9 | 0.19787520 |
| 163 | EPHB1 | 0.18131171 |
| 164 | PRKCZ | 0.14931956 |
| 165 | MAP2K1 | 0.14145424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 5.86147130 |
| 2 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 4.88163612 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.39565393 |
| 4 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 4.05040332 |
| 5 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 3.50798270 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.24801903 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.17452306 |
| 8 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.12053420 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 3.07354601 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.01058332 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.81322163 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.71670640 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.62619960 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.53551285 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 2.52621827 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.49000308 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 2.22497397 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.21785801 |
| 19 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.19323527 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.16829467 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12942561 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.11331606 |
| 23 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.09067207 |
| 24 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.06675021 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.98801583 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.88884221 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.78248836 |
| 28 | * Galactose metabolism_Homo sapiens_hsa00052 | 1.73856827 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69444903 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.67661959 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65499385 |
| 32 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.63307083 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.52028864 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51975439 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48474621 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47849384 |
| 37 | Base excision repair_Homo sapiens_hsa03410 | 1.46308693 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44386635 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.43755753 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41534011 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38064151 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.37479754 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35752759 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26864245 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24826720 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.22843356 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.20857845 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20025519 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19642028 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19375208 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18142822 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.16797925 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16670099 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.14695750 |
| 55 | Measles_Homo sapiens_hsa05162 | 1.13228378 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11092487 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.11011772 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10333794 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10044271 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09444263 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08802488 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07607134 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05290584 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.04772657 |
| 65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.98033354 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96634807 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.95379510 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95193694 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94011632 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93998082 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93863341 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93080447 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.92359797 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92061956 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.91998717 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.91264740 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90182680 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89632334 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89579878 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.87827998 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87511401 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86835631 |
| 83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.86533238 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.83291489 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83260810 |
| 86 | Cell cycle_Homo sapiens_hsa04110 | 0.81693742 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80169637 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80100715 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80017252 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79223091 |
| 91 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79177050 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78885555 |
| 93 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78311884 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.77998717 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77138096 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.76802632 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76390410 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76153565 |
| 99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75428051 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73687393 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73556148 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72434499 |
| 103 | RNA transport_Homo sapiens_hsa03013 | 0.68275921 |
| 104 | Proteasome_Homo sapiens_hsa03050 | 0.68180942 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68132369 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68085103 |
| 107 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67056288 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.66780376 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65520965 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.65191562 |
| 111 | RNA polymerase_Homo sapiens_hsa03020 | 0.64288132 |
| 112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64227842 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63603601 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63127103 |
| 115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62566964 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62230386 |
| 117 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60025552 |
| 118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59502158 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57273474 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.56862823 |
| 121 | Pertussis_Homo sapiens_hsa05133 | 0.55265580 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54974358 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54651980 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.54276745 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54236113 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53827743 |
| 127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52220852 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50149613 |
| 129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48537751 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48264037 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47569407 |
| 132 | Allograft rejection_Homo sapiens_hsa05330 | 0.46114532 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45998592 |
| 134 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45279438 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44880437 |
| 136 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44758209 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44571428 |
| 138 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43878210 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.43645073 |
| 140 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43562218 |
| 141 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42990145 |
| 142 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42014783 |
| 143 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41880397 |
| 144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41198819 |
| 145 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40966611 |
| 146 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40302442 |
| 147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40222476 |
| 148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38560728 |
| 149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37477673 |
| 150 | Hepatitis B_Homo sapiens_hsa05161 | 0.37041195 |
| 151 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35802269 |
| 152 | Purine metabolism_Homo sapiens_hsa00230 | 0.34736666 |
| 153 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34518377 |
| 154 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30329434 |
| 155 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29740189 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27908932 |
| 157 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26022077 |
| 158 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21761828 |
| 159 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19779364 |
| 160 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18057503 |
| 161 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.17273352 |
| 162 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.16128585 |
| 163 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.15906672 |
| 164 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15428588 |
| 165 | Prion diseases_Homo sapiens_hsa05020 | 0.15231529 |
| 166 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.12478081 |
| 167 | Lysine degradation_Homo sapiens_hsa00310 | 0.06597377 |
| 168 | Adherens junction_Homo sapiens_hsa04520 | 0.04860136 |
| 169 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1014122 |
| 170 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | -0.0991731 |
| 171 | Hepatitis C_Homo sapiens_hsa05160 | -0.0848555 |
| 172 | Tight junction_Homo sapiens_hsa04530 | -0.0358510 |
| 173 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0336363 |
| 174 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0304602 |
| 175 | Propanoate metabolism_Homo sapiens_hsa00640 | -0.0111560 |

